TREBIA ACQUISITION CORP-A (TREB) Stock Fundamental Analysis

NYSE:TREB

9.45
-1.03 (-9.83%)
Last: Jan 27, 2022, 08:56 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

TREB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. The financial health of TREB is average, but there are quite some concerns on its profitability. TREB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • TREB had negative earnings in the past year.
TREB Yearly Net Income VS EBIT VS OCF VS FCFTREB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 -5M -10M -15M -20M -25M

1.2 Ratios

Industry RankSector Rank
ROA -1.11%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TREB Yearly ROA, ROE, ROICTREB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 -2 -4 -6

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for TREB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TREB Yearly Profit, Operating, Gross MarginsTREB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • TREB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TREB Yearly Shares OutstandingTREB Yearly Shares OutstandingYearly Shares Outstanding 2020 20M 40M 60M
TREB Yearly Total Debt VS Total AssetsTREB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 100M 200M 300M 400M 500M

2.2 Solvency

  • TREB has an Altman-Z score of 6.16. This indicates that TREB is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for TREB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.16
ROIC/WACCN/A
WACCN/A
TREB Yearly LT Debt VS Equity VS FCFTREB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 0.11 indicates that TREB may have some problems paying its short term obligations.
  • A Quick Ratio of 0.11 indicates that TREB may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
TREB Yearly Current Assets VS Current LiabilitesTREB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 200K 400K 600K 800K 1M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4583.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • TREB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.09% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y165.06%
EPS Next 2Y55.89%
EPS Next 3Y41.78%
EPS Next 5Y28.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TREB Yearly Revenue VS EstimatesTREB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 500M 1B 1.5B
TREB Yearly EPS VS EstimatesTREB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • TREB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 45.19, the valuation of TREB can be described as expensive.
  • TREB is valuated expensively when we compare the Price/Forward Earnings ratio to 27.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 45.19
TREB Price Earnings VS Forward Price EarningsTREB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TREB Per share dataTREB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • TREB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as TREB's earnings are expected to grow with 41.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.89%
EPS Next 3Y41.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for TREB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

TREBIA ACQUISITION CORP-A

NYSE:TREB (1/27/2022, 8:56:30 PM)

9.45

-1.03 (-9.83%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.55%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap611.32M
Revenue(TTM)N/A
Net Income(TTM)-5.74M
Analysts82.5
Price Target19.38 (105.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 45.19
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0.21
Fwd EY2.21%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.11
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.11%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z 6.16
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4583.85%
EPS Next Y165.06%
EPS Next 2Y55.89%
EPS Next 3Y41.78%
EPS Next 5Y28.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

TREBIA ACQUISITION CORP-A / TREB FAQ

Can you provide the ChartMill fundamental rating for TREBIA ACQUISITION CORP-A?

ChartMill assigns a fundamental rating of 2 / 10 to TREB.


Can you provide the valuation status for TREBIA ACQUISITION CORP-A?

ChartMill assigns a valuation rating of 3 / 10 to TREBIA ACQUISITION CORP-A (TREB). This can be considered as Overvalued.


Can you provide the profitability details for TREBIA ACQUISITION CORP-A?

TREBIA ACQUISITION CORP-A (TREB) has a profitability rating of 1 / 10.


What is the financial health of TREBIA ACQUISITION CORP-A (TREB) stock?

The financial health rating of TREBIA ACQUISITION CORP-A (TREB) is 2 / 10.